Latest filing published 22 Jan 2013 for Alexza Pharmaceuticals Inc., €357k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Lansdowne Partners Austria GmbH: trading record in brief
Lansdowne Partners Austria GmbH appears in our data through filings on Alexza Pharmaceuticals Inc. shares, published by SEC (Form 4). The record holds 4 filings, for trades running from 27 December 2012 to 18 January 2013.
The open-market side counts 2 purchases for €265k alongside 2 sales for €446k. On balance, insiders were net sellers of €181k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2013, the count stands at no purchases and 2 sales.
The latest filing, published on 22 January 2013, reports an open-market sale of €357k in Alexza Pharmaceuticals Inc. The clock since the last published purchase (31 December 2012) now reads 5,060 days. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Lansdowne Partners Austria GmbH
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 100,000 shares@ US$4.75Common Stock $0.0001 par value per shareSEC:0000919574-13-000298:0
- 25,000 shares@ US$4.75Common Stock, $0.0001 par value per shareSEC:0000919574-13-000298:1
- 43,600 shares@ US$4.86Common Stock, $0.0001 par value per shareSEC:0000919574-12-006852:0Canonical exit: 27 Mar 2013 (T+90)
- 28,589 shares@ US$4.84Common Stock, $0.0001 par value per shareSEC:0000919574-12-006852:1Canonical exit: 27 Mar 2013 (T+90)
4 of 4 declarations
